Typicality: | 0.375 |
Saliency: | 0.292 |
for adding pertuzumab | 3 | purpose |
necessarily | 2 | degree |
benefit → be → nonexistent | 21 |
negative | neutral | positive |
0.442 | 0.462 | 0.097 |
Raw frequency | 21 |
Normalized frequency | 0.292 |
Modifier score | 0.500 |
Perplexity | 457.763 |